한국어 · English · 简体中文 · Русский · Bahasa Indonesia · ภาษาไทย · Tiếng Việt · 日本語

Approved ingredients

와사비잎 추출물(NCWL01)

와사비잎 추출물(NCWL01)

MFDS recognition no.2023-18
Approval routeNotified (고시형) — listed in MFDS public standards
Daily intake (as approved)250.0–250.0 mg
Approval holder(주) 엔에스쇼핑

Approved wording (Korean original)

체지방 감소에 도움을 줄 수 있음

Precautions (Korean original)

영·유아, 어린이, 임산부 및 수유부는 섭취에 주의할것, 특정질환(알레르기 체질 등)이 있는 분은 섭취에 주의할 것, 이상사례 발생 시 섭취를 중단하고 전문가와 상담할 것, 의약품(항응고제, 항혈소판제)을 복용하시는 분은 섭취 전 전문의와 상담할 것
the FDA, EFSA or your national authorityRequirements differ by market. Confirm ingredient status and label wording with your own authority before importing.

Sourcing from Korea

Last synchronised: 2026-07-22

Approvals described here were issued by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea and are valid in South Korea only. They are not health claims in your jurisdiction and have not been evaluated by the FDA, EFSA, or any other authority. This page reports regulatory facts and does not recommend any product.